Moody Lynn & Lieberson, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Moody Lynn & Lieberson, LLC

$1.47 Billion
Q2 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 1,022 shares of REGN stock, worth $1.02 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,022

Previous 4,575 77.66%

Holding current value

$1.02 Million

Previous $4.4 Million 75.61%

% of portfolio

0.07%

Previous 0.31%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$883.2 - $1071.19 $3.14 Million - $3.81 Million	-3,553 Reduced 77.66%	1,022 $1.07 Million
Q1 2024 Apr 23, 2024	BUY	$902.69 - $993.35 $49,647 - $54,634	55 Added 1.22%	4,575 $4.4 Million
Q4 2023 Jan 24, 2024	BUY	$775.18 - $881.7 $3.3 Million - $3.75 Million	4,253 Added 1592.88%	4,520 $3.97 Million
Q3 2023 Oct 24, 2023	BUY	$692.45 - $844.37 $184,884 - $225,446	267 New	267 $219,000
Q1 2023 May 02, 2023	SELL	$680.49 - $826.97 $2,721 - $3,307	-4 Reduced 0.09%	4,265 $3.5 Million
Q4 2022 Feb 01, 2023	SELL	$705.89 - $766.39 $3,529 - $3,831	-5 Reduced 0.12%	4,269 $3.08 Million
Q3 2022 Oct 26, 2022	SELL	$573.97 - $724.32 $1.94 Million - $2.45 Million	-3,387 Reduced 44.21%	4,274 $2.94 Million
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $210,566 - $283,714	-384 Reduced 4.77%	7,661 $4.53 Million
Q1 2022 Apr 27, 2022	BUY	$595.12 - $698.43 $4.79 Million - $5.62 Million	8,045 New	8,045 $5.62 Million
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $3.51 Million - $4.34 Million	-6,467 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$574.03 - $680.96 $3.71 Million - $4.4 Million	6,467 New	6,467 $3.91 Million
Q3 2020 Oct 28, 2020	SELL	$544.75 - $658.21 $4.96 Million - $5.99 Million	-9,108 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$493.32 - $643.92 $1.84 Million - $2.4 Million	3,721 Added 69.07%	9,108 $5.68 Million
Q1 2020 Apr 30, 2020	SELL	$336.18 - $494.43 $2.2 Million - $3.24 Million	-6,557 Reduced 54.9%	5,387 $2.63 Million
Q4 2019 Jan 28, 2020	BUY	$274.13 - $376.51 $3.27 Million - $4.5 Million	11,944 New	11,944 $4.49 Million

Others Institutions Holding REGN

# of Institutions

1,464

Shares Held

84.4M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $107B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Regeneron Pharmaceuticals, Inc. Transaction History